What Merck’s antiviral pill could mean for vaccine hesitancy — ‘It’s not a magic pill’

Merck and Ridgeback Therapeutics say molnupiravir cuts the risk of death or hospitalization in half
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.